skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search
view all search results
Search Close
Hamburger
profile Icon for Mobile

Adam Gakin

Associate

New York
T: +1 212.419.6039 F: +1 212.262.7402 agakin@lowenstein.com
  • BIO
  • EXPERIENCE
  • NEWS & INSIGHTS

See more section

Adam Gakin advises startups, funds, and both public and private companies on a wide range of corporate transactions, including mergers, acquisitions, divestitures and private equity control and minority investment transactions. With a focus on helping clients navigate complex deals, Adam has extensive experience with at-the-market securities offerings, debt financings, and general corporate governance.

Adam’s diverse clientele includes companies of all sizes across a range of sectors, from biopharma and media to investment advisory and wealth management and data warehousing.

Before entering the legal field, Adam gained valuable experience at Morgan Stanley as an equity research associate covering regional banks in the United States, where he developed financial models and engaged with clients and the equity sales team. He also interned with United First Partners LLC, a global investment and advisory firm specializing in Special Situations.

Adam is fluent in Russian.

  • Represented Hildred Capital Partners, LLC and its portfolio company Crown Laboratories, Inc., a global innovative leader in the skincare industry, in Crown’s $924M merger agreement with Revance Therapeutics, Inc. (NASDAQ: RVNC), a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings.

Education

  • Benjamin N. Cardozo School of Law (J.D. 2023); Cardozo Law Review

    Binghamton University (M.S. 2017)

    Binghamton University (B.S. 2016), magna cum laude; Dean’s List

Admissions

  • New York